SE8100104L - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number: SE8100104L
Authority: SE; Sweden
Prior art keywords: amount; milligrams; release controlling; agent; controlling agent
Prior art date: 1980-01-11

Application number

SE8100104A

Other languages

Unknown language ( )

English (en)

Other versions

SE447450B (sv

Inventor

J M Dunn

J F Lampard

Original Assignee

Boots Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-01-11

Filing date

1981-01-09

Publication date

1981-07-12

1980-10-17 Priority claimed from US06/194,453 external-priority patent/US4308251A/en

1981-01-09 Application filed by Boots Co Ltd filed Critical Boots Co Ltd

1981-07-12 Publication of SE8100104L publication Critical patent/SE8100104L/sv

1986-11-17 Publication of SE447450B publication Critical patent/SE447450B/sv

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 7
239000003814 drug Substances 0.000 abstract 3
230000003628 erosive effect Effects 0.000 abstract 3
230000001737 promoting effect Effects 0.000 abstract 3
229940124597 therapeutic agent Drugs 0.000 abstract 3
BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 abstract 1
229920000623 Cellulose acetate phthalate Polymers 0.000 abstract 1
229920002261 Corn starch Polymers 0.000 abstract 1
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
229940081734 cellulose acetate phthalate Drugs 0.000 abstract 1
239000008120 corn starch Substances 0.000 abstract 1
229960002390 flurbiprofen Drugs 0.000 abstract 1
SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 abstract 1
229960001680 ibuprofen Drugs 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SE8100104A 1980-01-11 1981-01-09 Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa SE447450B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11143080A	1980-01-11	1980-01-11
US06/194,453 US4308251A (en)	1980-01-11	1980-10-17	Controlled release formulations of orally-active medicaments

Publications (2)

Publication Number	Publication Date
SE8100104L true SE8100104L (sv)	1981-07-12
SE447450B SE447450B (sv)	1986-11-17

Family

ID=26808896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8100104A SE447450B (sv)	1980-01-11	1981-01-09	Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa

Country Status (22)

Country	Link
JP (1)	JPS56103110A (sv)
AT (1)	AT374681B (sv)
AU (1)	AU542824B2 (sv)
BE (1)	BE886998A (sv)
CA (1)	CA1140466A (sv)
CH (1)	CH646604A5 (sv)
DE (1)	DE3100191A1 (sv)
DK (1)	DK6181A (sv)
ES (2)	ES8205353A1 (sv)
FI (1)	FI76927C (sv)
FR (1)	FR2473308B1 (sv)
GB (1)	GB2067072B (sv)
GR (1)	GR73843B (sv)
IE (1)	IE50806B1 (sv)
IN (1)	IN151913B (sv)
IT (1)	IT1221041B (sv)
LU (1)	LU83052A1 (sv)
NL (1)	NL8100037A (sv)
NO (1)	NO156153C (sv)
NZ (1)	NZ195933A (sv)
SE (1)	SE447450B (sv)
ZA (1)	ZA81136B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2496082A (en) *	1947-05-24	1950-01-31	Ashenfelter William	Scaffold structure
IT1144911B (it) *	1981-03-19	1986-10-29	Pharmatec Spa	Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) *	1983-06-07	1984-12-21	Toyo Jozo Co Ltd	持続性経口用ブレデニン製剤
JPH0662404B2 (ja) *	1983-06-14	1994-08-17	シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド	制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) *	1983-08-16	1985-02-27	Verex Lab	Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) *	1983-08-16	1985-02-27	Verex Lab	Constant release rate solid dosage theophylline formulation
US4774091A (en) *	1983-10-14	1988-09-27	Sumitomo Pharmaceuticals Company, Ltd.	Long-term sustained-release preparation
US4855134A (en) *	1983-10-14	1989-08-08	Sumitomo Pharmaceuticals Company, Limited	Sustained-release preparation
DE3486029T2 (de) *	1983-10-14	1993-05-13	Sumitomo Pharma	Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung.
US5385738A (en) *	1983-10-14	1995-01-31	Sumitomo Pharmaceuticals Company, Ltd.	Sustained-release injection
CA1277601C (en) *	1985-12-27	1990-12-11	Shigeji Sato	Method for producing sustained release formulation
GB8601204D0 (en) *	1986-01-18	1986-02-19	Boots Co Plc	Therapeutic agents
US4968508A (en) *	1987-02-27	1990-11-06	Eli Lilly And Company	Sustained release matrix
IL85538A (en) *	1987-02-27	1991-09-16	Lilly Co Eli	Sustained release matrix tablet formulations containing hydrophilic and enteric polymers
AU6403196A (en) *	1995-06-30	1997-02-05	Baylor University	Polyester/carboxylic acid composite materials

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2953497A (en) *	1953-06-03	1960-09-20	Howard A Press	Therapeutic tablets
BE604564A (sv) *	1960-06-06
US3577514A (en) *	1968-06-10	1971-05-04	Pfizer	Sustained release pharmaceutical tablets
US3773920A (en) *	1971-07-14	1973-11-20	Nikken Chemicals Co Ltd	Sustained release medicinal composition
US3906086A (en) *	1971-07-19	1975-09-16	Richard G Powers	Timed-release aspirin
GB1500300A (en) *	1975-01-06	1978-02-08	Ciba Geigy Ag	Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) *	1977-06-24	1979-01-27	Shin Etsu Chem Co Ltd	Disintegratable granule

1980
- 1980-12-23 IN IN1418/CAL/80A patent/IN151913B/en unknown
- 1980-12-23 NZ NZ195933A patent/NZ195933A/xx unknown
1981
- 1981-01-05 AU AU65976/81A patent/AU542824B2/en not_active Ceased
- 1981-01-06 FR FR8100087A patent/FR2473308B1/fr not_active Expired
- 1981-01-07 NL NL8100037A patent/NL8100037A/nl not_active Application Discontinuation
- 1981-01-07 DE DE19813100191 patent/DE3100191A1/de active Granted
- 1981-01-08 CH CH9281A patent/CH646604A5/fr not_active IP Right Cessation
- 1981-01-08 DK DK6181A patent/DK6181A/da not_active Application Discontinuation
- 1981-01-08 BE BE0/203426A patent/BE886998A/fr unknown
- 1981-01-08 GB GB8100522A patent/GB2067072B/en not_active Expired
- 1981-01-08 ES ES498369A patent/ES8205353A1/es not_active Expired
- 1981-01-08 JP JP157881A patent/JPS56103110A/ja active Pending
- 1981-01-09 LU LU83052A patent/LU83052A1/fr unknown
- 1981-01-09 NO NO810062A patent/NO156153C/no unknown
- 1981-01-09 ZA ZA00810136A patent/ZA81136B/xx unknown
- 1981-01-09 CA CA000368219A patent/CA1140466A/en not_active Expired
- 1981-01-09 FI FI810056A patent/FI76927C/sv not_active IP Right Cessation
- 1981-01-09 GR GR63828A patent/GR73843B/el unknown
- 1981-01-09 SE SE8100104A patent/SE447450B/sv not_active IP Right Cessation
- 1981-01-09 IT IT47537/81A patent/IT1221041B/it active
- 1981-01-09 IE IE36/81A patent/IE50806B1/en unknown
- 1981-01-09 AT AT0005481A patent/AT374681B/de not_active IP Right Cessation
1982
- 1982-01-29 ES ES509179A patent/ES509179A0/es active Granted

Also Published As

Publication number	Publication date
NO156153C (no)	1987-08-05
IT8147537A0 (it)	1981-01-09
GB2067072B (en)	1983-08-10
IN151913B (sv)	1983-09-03
GR73843B (sv)	1984-05-07
FI810056L (fi)	1981-07-12
SE447450B (sv)	1986-11-17
ATA5481A (de)	1983-10-15
JPS56103110A (en)	1981-08-18
BE886998A (fr)	1981-07-08
ES8301629A1 (es)	1982-12-16
ES498369A0 (es)	1982-06-01
AU542824B2 (en)	1985-03-14
CH646604A5 (fr)	1984-12-14
NL8100037A (nl)	1981-08-03
IE810036L (en)	1981-07-11
NZ195933A (en)	1982-11-23
FR2473308B1 (fr)	1985-07-19
IT1221041B (it)	1990-06-21
FI76927B (fi)	1988-09-30
ES8205353A1 (es)	1982-06-01
AU6597681A (en)	1981-07-16
AT374681B (de)	1984-05-25
ZA81136B (en)	1982-01-27
ES509179A0 (es)	1982-12-16
LU83052A1 (fr)	1982-09-10
DE3100191A1 (de)	1981-12-10
DE3100191C2 (sv)	1988-09-01
IE50806B1 (en)	1986-07-23
GB2067072A (en)	1981-07-22
NO810062L (no)	1981-07-13
CA1140466A (en)	1983-02-01
NO156153B (no)	1987-04-27
DK6181A (da)	1981-07-12
FR2473308A1 (fr)	1981-07-17
FI76927C (sv)	1989-01-10

Similar Documents

Publication	Publication Date	Title
IE810036L (en)	1981-07-11	Sustained release compositions
IT8421720A1 (it)	1986-01-02	Formulazioni farmaceutiche solide destinate ad essere liberate lentamente, di ordine zero, tramite erosione superficiale controllata di ampia portata
DK0607467T3 (da)	1999-12-13	Lægemidler, der indeholder S(+)-ibuprofen
NO161257C (no)	1989-07-26	Analogifremgangsm te for fremstilling av antiviralt aktive pyridazinaminer.
FR2430410A1 (fr)	1980-02-01	Phenethanolamines et compositions pharmaceutiques en contenant
ES424533A1 (es)	1977-02-16	Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa.
LV5801B4 (lv)	1997-12-20	Omeprazola pievienotas bazes sali
IE791172L (en)	1979-12-16	Pharmaceutical compositions containing urea
ES8502334A1 (es)	1985-01-01	"un procedimiento para preparar una composicion que contiene elastasa".
ES465906A1 (es)	1979-01-01	Un procedimiento de preparacion de comprimidos
GB1353635A (en)	1974-05-22	Coating composition for moist surfaces
NO891220D0 (no)	1989-03-20	Middel som inneholder salicylsyre for behandling av lepidose.
ES433860A1 (es)	1976-11-16	Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
FR2413909A1 (fr)	1979-08-03	Compositions therapeutiques a base de 1-(2-chlorodibenzo(b,f)oxepine-10-yl)-4-methylpiperazine
BE830577A (fr)	1975-12-24	Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
ES466493A1 (es)	1979-05-01	Procedimiento de fabricacion de acidos a-aril-a -oxo-isovalericos.
GB1381426A (en)	1975-01-22	Method of treating mammals and composition comprising oligosaccha ride sulphuric acid esters and nonionic surface active agents
FR2380778A1 (fr)	1978-09-15	Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters
ATE16100T1 (de)	1985-11-15	Ester der 1-methyl-5-p-toluoylpyrrolyl-2essigs\|ure mit antiinflammatorischen, mucolytischen und antitussiven eigenschaften, verfahren zu seiner herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AU645205B2 (en)	1994-01-06	Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions
LU81501A1 (fr)	1979-10-31	Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
JPS56122312A (en)	1981-09-25	Hepatic cholesterol-lowering agent (hepatic decholesterolizing agent)
PT69341A (fr)	1979-04-01	Procede pour la preparation de compositions pharmaceutiques solides contenant gefarnate
GB1253786A (en)	1971-11-17	Therapeutic compositions
GB1449441A (en)	1976-09-15	Agnets for lowering the lipid level in plasma

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 8100104-2

Effective date: 19901211

Format of ref document f/p: F